Author: Eleanor Garth – LongevityTechnology

Ahead of the Longevity Investors Conference, our longevity hivemind talks biomarkers, translation and the democratisation of regenerative medicine.

Yesterday, we brought you the first installment in our longevity’s burning questions series, in which we ask some of the longevity heavyweights and pioneers speaking at the upcoming Longevity Investors Conference their views on some of the significant issues in the antiaging field.

Longevity.Technology: Longevity is on its way to becoming the most significant investment opportunity available; the Longevity Investors Conference targets the global investor community and brings a whole range of institutional investors together with top class and longevity-experienced speakers. Later this month they will together explore relevant insights into the field, expert education and investment opportunities, as well as enjoying excellent networking possibilities in the scenic and exclusive town of Gstaad.

Read the full article here